-
AN-7
- names:
butyroyloxymethyl diethylphosphate
- CAS號:
213262-83-0
MDL Number: - MF(分子式): C9H19O6P MW(分子量): 254.21732
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 貨品編碼 | 規格 | 純度 | 價格 (¥) | 現價(¥) | 特價(¥) | 庫存描述 | 數量 | 總計 (¥) |
|---|
| 中文別名 | AN-7 |
| 英文別名 | AN7; AN-7; AN 7; butyroyloxymethyl diethylphosphate |
| CAS號 | 213262-83-0 |
| Inchi | InChI=1S/C9H19O6P/c1-4-7-9(10)12-8-15-16(11,13-5-2)14-6-3/h4-8H2,1-3H3 |
| InchiKey | UGIGKLCVADLBRB-UHFFFAOYSA-N |
| 分子式 Formula | C9H19O6P |
| 分子量 Molecular Weight | 254.21732 |
| 溶解度Solubility | |
| 性狀 | Solid powder |
| 儲藏條件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 產品說明 | AN-7(CAS:213262-83-0):僅限應用于工業或者科學研究過程中非醫療目的,不應用于人類或動物的臨床診斷以及治過程療,該產品非藥用,非食用。 |
| Introduction | AN-7 is a potent HDAC inhibitor, is also a prodrug of butyric acid, which induced histone hyperacetylation and differentiation and inhibited proliferation of human prostate 22Rv1 cancer cells in vitro and in vivo. AN-7 is likely to display a high therapeutic index and may be beneficial for prostate cancer patients. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Tarasenko N, Cutts SM, Phillips DR, Inbal A, Nudelman A, Kessler-Icekson G, Rephaeli A. Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor. PLoS One. 2012;7(2):e31393. doi: 10.1371/journal.pone.0031393. Epub 2012 Feb 23. PubMed PMID: 22384017; PubMed Central PMCID: PMC3285631. |
| [2]Tarasenko N, Kessler-Icekson G, Boer P, Inbal A, Schlesinger H, Phillips DR, Cutts SM, Nudelman A, Rephaeli A. The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity. Invest New Drugs. 2012 Feb;30(1):130-43. doi: 10.1007/s10637-010-9542-z. Epub 2010 Sep 23. PubMed PMID: 20862515. |
| [3] Tarasenko N, Nudelman A, Tarasenko I, Entin-Meer M, Hass-Kogan D, Inbal A, Rephaeli A. Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex). Clin Exp Metastasis. 2008;25(7):703-16. doi: 10.1007/s10585-008-9179-x. Epub 2008 May 28. PubMed PMID: 18506586. |
| [4] Blank-Porat D, Gruss-Fischer T, Tarasenko N, Malik Z, Nudelman A, Rephaeli A. The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties. Cancer Lett. 2007 Oct 18;256(1):39-48. Epub 2007 Jul 3. PubMed PMID: 17611019. |
| [5] Engel D, Nudelman A, Levovich I, Gruss-Fischer T, Entin-Meer M, Phillips DR, Cutts SM, Rephaeli A. Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7/Dx cell lines. J Cancer Res Clin Oncol. 2006 Oct;132(10):673-83. Epub 2006 Jul 7. PubMed PMID: 16826403. |
- 相關產品
-
< >
- 推薦產品
-
< >
- 最新產品
-
< >
新聞

怎么做細胞爬片免疫組化染色實驗
細胞爬片免疫組化染色,是通過細胞爬片是讓玻片浸在細胞培養基內,細胞在玻片上生長,主要用于組織學,免疫組織化學...
2020/7/20 22:04:33

提取病毒RNA的實驗方法
提取病毒RNA方法分別有:異硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26

細胞培養耗材技術領先性
細胞培養板行業面臨的核心痛點是:常規TC處理后表面親水角隨時間衰減,影響長期培養穩定性,BIOFOUNT高分...
2026/4/28 15:12:51

細胞培養耗材關鍵性能
細胞培養板的水接觸角作為表面潤濕性的核心指標,直接影響細胞貼壁、增殖、分化及功能表達,其中40°(低接觸角/...
2026/4/28 14:52:44

chelex 100樹脂國產替代之路-BIOFOUNT范德生物
Chelex 100螯合離子交換樹脂對銅、鐵和其他重金屬?的偏好顯著高于對鈉、鉀等一價陽離子的偏好。它對二價...
2025/11/4 14:22:46

9月開學季——助研新學期 范德送好禮
2025/8/28 15:30:55

Waxfilm 實驗室封口膜:技術與國際市場的雙重突破
在實驗室耗材領域,封口膜是保障實驗準確性與穩定性的關鍵產品之一。近年來,Waxfilm?實驗室封口膜憑借其卓...
2025/5/13 13:03:40

Waxfilm實驗室封口膜的5大突破
Waxfilm實驗室封口膜作為生物功能膜領域的國產技術突破和品牌突破,是生物領域中國技術發展的縮影。
2025/5/6 17:02:07

各種微流控芯片鍵合方法的優缺點
微流控芯片鍵合:目前主要有激光焊接、熱壓鍵合、膠鍵合、超音波焊接,每種方法都有各自的優缺點。本文主要介紹聚酯...
2023/7/28 10:43:09

新一代微流控鍵合解決方案
微流控鍵合解決方案:微流控芯片制造的一個重要環節,也是最容易被忽視的--芯片鍵合。其中一個重要因素是:微流控...
2023/7/27 12:44:28


購物車 


